• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VASCUTEK LTD. THORAFLEX HYBRID; THORAFLEX HYBRID PLEXUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VASCUTEK LTD. THORAFLEX HYBRID; THORAFLEX HYBRID PLEXUS Back to Search Results
Catalog Number THP3036X100B-G
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Insufficient Information (4580)
Event Date 08/05/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).Historical data analysis - a five year review of similar reported events of endoleak type i in thoraflex hybrid branded grafts was completed, an occurrence rate of 0.094% was confirmed.No negative trend in the number of events reported was identified.Trend analysis - no negative trend was identified.Communication / interviews - further information - scans have been requested from the site.Device not available for testing - device remains in situ.Analysis of production records - the review of quality, manufacturing and physical test records showed that the device was manufactured to the intended specifications.No issue has been found upon review of the retained device history records for this device conclusion is not yet available - additional information and ct scans has been requested from the study site.
 
Event Description
Event reported via thor study as type 1b endoleak distal end of stent graft.The severity of the event has been reported as mild, and the outcome as unresolved.An endovascular stent extension is planned.While the site have entered this event as unanticipated, endoleaks are anticipated per protocol.
 
Manufacturer Narrative
Investigation findings: 213 - no device problem found.- retained manufacturing records were reviewed and showed the device was manufactured to specification, on (b)(6) 2022 ct scans were received and reviewed.The conclusion from the review is as follows: the thoraflex hybrid device did not create a distal seal due to insufficient oversizing of the device.The device was also not extended distally to obtain a distal seal, resulting in a type 1b endoleak and increased dilatation of the descending aorta.The review of the scans confirmed that the diameter for the distal ring of the device is 36.5mm.That verifies that the device sizing listed on the label matches the device that was used.Investigation conclusion: 18 - the root cause of the event was determined to be procedure not followed.Thoraflex hybrid ifu provides instructions on what size of the device should be chosen depending on the size of the dissection (301-192_1 thoraflex hybrid gen2 set a, section 2 pages 9 and 10).
 
Event Description
This report is being submitted as follow up #1 for mfg.Report# 9612515-2022-00014 comp (b)(4)to provide event closure information and updated device details.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THORAFLEX HYBRID
Type of Device
THORAFLEX HYBRID PLEXUS
Manufacturer (Section D)
VASCUTEK LTD.
newmains avenue
inchinnan business park
renfrewshire PA4 9 RR
UK  PA4 9RR
Manufacturer (Section G)
VASCUTEK LTD.
newmains avenue
inchinnan business park
renfrewshire PA4 9 RR
UK   PA4 9RR
Manufacturer Contact
jason whittle
newmains avenue
inchinnan business park
glasgow, renfrewshire PA4 9-RR
UK   PA4 9RR
MDR Report Key15491844
MDR Text Key300652170
Report Number9612515-2022-00014
Device Sequence Number1
Product Code QSK
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K090987
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/01/2020
Device Catalogue NumberTHP3036X100B-G
Device Lot Number17606685
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/01/2022
Initial Date FDA Received09/27/2022
Supplement Dates Manufacturer Received09/01/2022
Supplement Dates FDA Received11/29/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured10/07/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient SexMale
-
-